© 2001-2024 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG > Modern Slavery Act Statement 2024 (PDF -...
GSK plc. Registered in England and Wales No. 3888792. Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG > Modern Slavery Act statement 2023 (PDF - 139.1KB) GSK websites Locations selector Social media directory GSKPro for healthcare professionals GSK study reg...
GSK plc. Registered in England and Wales No. 3888792. Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG > Modern Slavery Act Statement 2024 (PDF - 162.5KB) GSK websites Locations selector Social media directory GSKPro for healthcare professionals GSK study reg...
GlaxoSmithKline plc is one of the leading pharmaceutical companies worldwide. The multinational company is headquartered in London, UK. In 2024, the company generated a total of some 31.4 billion British pounds of revenue, compared to 30.3 billion in 2023. The lower revenue figures from 2022 on ...
GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Affinivax, Inc (Affinivax), a clinical-stage biopharmaceutical company based in Cambridge (Boston, Massachusetts). Affinivax has pioneered the development of a novel class of vaccines, the most advanced of which are next...
GSK Pakistan Annual Report 2024 Quarterly results You might also like Our products We research and develop a broad range of innovative products Pharmaceuticals and Vaccines Career opportunities at GSK Discover the work we do and the opportunities that exist, from research and development through to ma...
GSK PLC Calendar GSK plc Equities GSK GB00BN7SWP63 Pharmaceuticals Market Closed -London S.E. 11:35:04 2025-04-17 am EDT5-day change1st Jan Change 1,336.50GBX-0.67% +3.28%-0.74% Apr. 17GSK Says Health Canada Approves Expanded Jemperli IndicationMT ...
GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Affinivax, Inc (Affinivax), a clinical-stage biopharmaceutical company based in Cambridge (Boston, Massachusetts). Affinivax has pioneered the development of a novel class of vaccines, the most advanced of which are next...
GSK plc 2023 Q3 - Results - Earnings Call PresentationWed, Nov. 01, 2023 See All Investor Presentations » GLAXF SEC Filings Type:All GSK plc (GLAXF) - 6-K - Report of Foreign IssuerSEC FilingsTue, Feb. 11 GSK plc (GLAXF) - 6-K - Report of Foreign IssuerSEC FilingsWed, Feb....
HS-20093 has shown promising initial clinical activity in lung cancer with potential to address unmet medical need in broader solid tumour indications (20 December 2023, London UK)GSK plc (LSE/NYSE: GSK) and Hansoh Pharma (HKEX: 03692), a Chinese biopharmaceutical company committed to discovering...